This document summarizes a study investigating the gene expression and localization of group I metabotropic glutamate receptors (mGluRs) in the adult zebrafish brain. The study aims to determine if mGluR1 and mGluR5 are present at high levels in the adult zebrafish brain at the gene expression and protein localization levels. Methods include RNA extraction from zebrafish brains followed by RT-PCR and real-time PCR to analyze mGluR1 and mGluR5 gene expression. Immunohistochemistry will also be used to determine the localization of mGluR1 and mGluR5 proteins in zebrafish brain sections. Results may provide insights into using zebrafish models to study neurological diseases
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...InsideScientific
Cerebral open flow microperfusion (cOFM) is a minimally invasive, in vivo sampling technology that allows continuous long-term sampling of cerebral fluid in living animals. The decisive advantage of cOFM is that the cOFM probe is membrane–free and comprises macroscopic openings which offer the possibility for a multitude of applications without restriction regarding size, lipophilicity or protein binding effects of the collected substances. The cOFM probe is designed to elicit minimal tissue reactions and allows for reconstitution of the blood-brain barrier (BBB). Thus, cOFM can sample cerebral fluids in living and freely moving animals with intact BBB.
During this webinar, Dr. Joanna Hummer introduces cOFM and presents how cOFM is used as an in vivo sampling technology in neuroscience for drug development.
Dr. Florie Le Prieult, presents data her team collected using cOFM during a pharmacokinetic studies of therapeutic antibodies. Her study includes head-to-head comparison of cOFM and microdialysis.
Self Head Fixation Training for the Study of Perceptual Decisions in MiceInsideScientific
In this webinar, Andrea Benucci, PhD will discuss a setup developed in his laboratory for high-throughput behavioral training of mice based on voluntary head fixation. He will describe its flexible use for behavioral training and concurrent neural recordings, delving into some technical considerations related to user-specific customizations as well.
In Andrea’s lab, they study the neural substrate of visual processing and vision-based decision making. To this end, they aim to define a research framework capable of linking neural architectures to the underlying computations. The solution they have developed is to integrate experimental methods for all-optical dissection of neuronal circuits with large-scale dynamical network models based on artificial neural networks (aNNs). The connectivity architecture of aNNs closely mirror that of biological neural networks, thus representing an effective theoretical framework to unify computational, algorithmic, and implementation levels of analysis.
Finally, Andrea will present some examples of unique research achievements made possible by the use of this setup.
Functional Ultrasound (fUS) Imaging in the Brain of Awake Behaving MiceInsideScientific
To watch the webinar, visit:
https://insidescientific.com/webinar/functional-ultrasound-imaging-brain-awake-behaving-mice-neurotar-iconeus
Functional ultrasound (fUS) imaging is a new kid on the block in neuroimaging. It combines high spaciotemporal resolution with deep tissue penetration, which enables non-invasive whole-brain imaging in mice.
This exciting new technology complements and extends classical imaging modalities: it enables more straightforward, unobstructed and non-invasive functional measurements in mouse models of CNS diseases. Sensitive to changes in cerebral blood volume, fUS imaging is used to characterize brain networks with functional connectivity analysis and to measure the responses to sensory stimuli and pharmacological challenges.
fUS imaging performed in the brain of awake mice removes the biases and artifacts associated with the use of general anesthesia, which is no longer a “necessary evil” of translational imaging. Besides that: fUS imaging in awake mice allows integrating functional imaging with behavioral readouts starting from open field locomotion tracking to maze navigation and sociability studies.
In this webinar, you will learn:
– Functional ultrasound (fUS) imaging methodology
– How translational fUS neuroimaging helps to advance basic neuroscience research and preclinical drug discovery
– The main advantages and limitations of using functional ultrasound compared to other techniques such as BOLD fMRI
– The benefits of imaging in awake, head-restrained but otherwise freely moving mice
– Imaging functional activation, connectivity and pharmacologically-induced changes in awake and behaving mice
– How to combine fUS imaging with behavioral observation
Vesicular systems have been realized as extremely useful carrier systems in various scientific domains. Over the years, vesicular systems have been investigated as a major drug delivery system, due to their flexibility to be tailored for varied desirable purposes. In spite of certain drawbacks, the vesicular delivery systems still play an important role in the selective targeting, and the controlled delivery of various drugs. Researchers all over the world continue to put in their efforts in improving the vesicular system by making them steady in nature, in order to prevent leaching of contents, oxidation, and their uptake by natural defense mechanisms.
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...InsideScientific
Cerebral open flow microperfusion (cOFM) is a minimally invasive, in vivo sampling technology that allows continuous long-term sampling of cerebral fluid in living animals. The decisive advantage of cOFM is that the cOFM probe is membrane–free and comprises macroscopic openings which offer the possibility for a multitude of applications without restriction regarding size, lipophilicity or protein binding effects of the collected substances. The cOFM probe is designed to elicit minimal tissue reactions and allows for reconstitution of the blood-brain barrier (BBB). Thus, cOFM can sample cerebral fluids in living and freely moving animals with intact BBB.
During this webinar, Dr. Joanna Hummer introduces cOFM and presents how cOFM is used as an in vivo sampling technology in neuroscience for drug development.
Dr. Florie Le Prieult, presents data her team collected using cOFM during a pharmacokinetic studies of therapeutic antibodies. Her study includes head-to-head comparison of cOFM and microdialysis.
Self Head Fixation Training for the Study of Perceptual Decisions in MiceInsideScientific
In this webinar, Andrea Benucci, PhD will discuss a setup developed in his laboratory for high-throughput behavioral training of mice based on voluntary head fixation. He will describe its flexible use for behavioral training and concurrent neural recordings, delving into some technical considerations related to user-specific customizations as well.
In Andrea’s lab, they study the neural substrate of visual processing and vision-based decision making. To this end, they aim to define a research framework capable of linking neural architectures to the underlying computations. The solution they have developed is to integrate experimental methods for all-optical dissection of neuronal circuits with large-scale dynamical network models based on artificial neural networks (aNNs). The connectivity architecture of aNNs closely mirror that of biological neural networks, thus representing an effective theoretical framework to unify computational, algorithmic, and implementation levels of analysis.
Finally, Andrea will present some examples of unique research achievements made possible by the use of this setup.
Functional Ultrasound (fUS) Imaging in the Brain of Awake Behaving MiceInsideScientific
To watch the webinar, visit:
https://insidescientific.com/webinar/functional-ultrasound-imaging-brain-awake-behaving-mice-neurotar-iconeus
Functional ultrasound (fUS) imaging is a new kid on the block in neuroimaging. It combines high spaciotemporal resolution with deep tissue penetration, which enables non-invasive whole-brain imaging in mice.
This exciting new technology complements and extends classical imaging modalities: it enables more straightforward, unobstructed and non-invasive functional measurements in mouse models of CNS diseases. Sensitive to changes in cerebral blood volume, fUS imaging is used to characterize brain networks with functional connectivity analysis and to measure the responses to sensory stimuli and pharmacological challenges.
fUS imaging performed in the brain of awake mice removes the biases and artifacts associated with the use of general anesthesia, which is no longer a “necessary evil” of translational imaging. Besides that: fUS imaging in awake mice allows integrating functional imaging with behavioral readouts starting from open field locomotion tracking to maze navigation and sociability studies.
In this webinar, you will learn:
– Functional ultrasound (fUS) imaging methodology
– How translational fUS neuroimaging helps to advance basic neuroscience research and preclinical drug discovery
– The main advantages and limitations of using functional ultrasound compared to other techniques such as BOLD fMRI
– The benefits of imaging in awake, head-restrained but otherwise freely moving mice
– Imaging functional activation, connectivity and pharmacologically-induced changes in awake and behaving mice
– How to combine fUS imaging with behavioral observation
Vesicular systems have been realized as extremely useful carrier systems in various scientific domains. Over the years, vesicular systems have been investigated as a major drug delivery system, due to their flexibility to be tailored for varied desirable purposes. In spite of certain drawbacks, the vesicular delivery systems still play an important role in the selective targeting, and the controlled delivery of various drugs. Researchers all over the world continue to put in their efforts in improving the vesicular system by making them steady in nature, in order to prevent leaching of contents, oxidation, and their uptake by natural defense mechanisms.
Pharmacosomes are the colloidal dispersions of drugs covalently bound to lipids, and may exist as ultrafine vesicular, micellar, or hexagonal aggregates, depending on the chemical structure of drug-lipid complex.
A Transfersome carrier is an artificial vesicle or a cell engaged in exocytosis, and thus suitable for controlled and, potentially targeted drug delivery,.
A comprehensive presentation on Enzymology :Types of Enzyme inhibition & Therapeutic uses for MBBS ,BDS, B Pharm & Biotechnology students to facilitate self- study.
The current slide focuses on different screening models for neurodegenerative diseases along with a brief description of the diseases where the slides are to the points and brief with detailed evaluation.
74th ICREA Colloquium "Autoimmunity meets neurodegeneration: different pathwa...ICREA
Studies during the last 10 years have revealed a new category of brain diseases in which crucial neuronal receptors are attacked by autoantibodies. As a result of this attack there is a reduction of the target synaptic proteins leading to alterations in synaptic transmission. The clinical manifestations vary according to the receptor involved, and may resemble many of the symptoms caused by neurodegenerative diseases in which specific receptors are involved, including among others Parkinson, epilepsy, chronically progressive sleep disease, or schizophrenia.
Pharmacosomes are the colloidal dispersions of drugs covalently bound to lipids, and may exist as ultrafine vesicular, micellar, or hexagonal aggregates, depending on the chemical structure of drug-lipid complex.
A Transfersome carrier is an artificial vesicle or a cell engaged in exocytosis, and thus suitable for controlled and, potentially targeted drug delivery,.
A comprehensive presentation on Enzymology :Types of Enzyme inhibition & Therapeutic uses for MBBS ,BDS, B Pharm & Biotechnology students to facilitate self- study.
The current slide focuses on different screening models for neurodegenerative diseases along with a brief description of the diseases where the slides are to the points and brief with detailed evaluation.
74th ICREA Colloquium "Autoimmunity meets neurodegeneration: different pathwa...ICREA
Studies during the last 10 years have revealed a new category of brain diseases in which crucial neuronal receptors are attacked by autoantibodies. As a result of this attack there is a reduction of the target synaptic proteins leading to alterations in synaptic transmission. The clinical manifestations vary according to the receptor involved, and may resemble many of the symptoms caused by neurodegenerative diseases in which specific receptors are involved, including among others Parkinson, epilepsy, chronically progressive sleep disease, or schizophrenia.
CMRR workshop in vivo GABA Glutamate and fMRI BOLD imaging Event-Related fMRSUzay Emir
CMRR workshop
Time-Resolved fMRI-fMRS measures simultaneous Neurotransmitters and BOLD-fMRI signals in the human brain at 7T
GABA Glutamate UHF Semi-laser
Advanced Magnetic Resonance Spectroscopy Protocol at 7T
7T hardware (Siemens Scanner and Nova Medical head coil), BaTiO3 dielectric padding
Ip et al., 2017 NeuroImage
Event-Related fMRS A transient break in excitatory-inhibitory balance
4. Why Zebrafish?
• 80% of homology
• Popular novel model in translational neuroscience research
• Both larval and adult zebrafish contribute to modeling complex brain
disorders.
• Zebrafish models can be used to study brain cancer, epilepsy, anxiety,
and autism.
• Zebrafish are a useful tool for genetic and small molecule screening.
5. mGluR 1 and mGluR 5
• Both G-proteins are coupled to phospholipase C and intracellular calcium
signalling
• mGluR 1 is linked to plasticity and long-term depression
• Learning and Memory
• mGluR Group I are found at high levels in (rat brain):
• Cerebellum
• Thalamus
• Olfactory bulb
• mGluR 1 is a potential therapeutic target for neurological diseases,
including:
• Schizophrenia
• Epilepsy
• Parkinson and Alzheimer diseases
6. Research Hypothesis
• We hypothesize that mGluRs group I is present at high level, at gene
expression and protein localization, in adult Zebrafish brain.
7. Specific Aims
• Specific Aim #1: To determine the gene expression of mGluR 1 and
mGluR 5 in whole-brain adult Zebrafish
• Specific Aim #2: To determine localization of mGluR 1 and mGluR 5 in
whole-brain adult Zebrafish.
9. Research Methods
Zebrafish + H2O + isoflurane
Zebrafish Brain Dissection
4% Formaldehyde
Series Alcohol
Dehydration/Methyl
salicylate
Microtome Section 4
mm (Standard)
RNeasy
kit (Qiagen)
RT-PCR
and Real-
Time PCR
10. Specific Aim #1
• To determine the gene expression of mGluR 1 and mGluR 5 in whole-
brain adult Zebrafish.
• Dissection of Zebrafish adult brain
• anesthetize fish in 120uL/50ml dilution of isoflurane
• RNA extraction and RT-PCR
• 20 adult wildtype Zebrafish brain (AllPrep DNA/RNA/Protein Qiagen kit, 20mg)
• mGluR 1: Primer Forward 5’ TACAACCCCTCAAACAGCCC 3’, Primer Reverse: 3’
CGTGCCACAACAGAACAGTG 5’
• mGluR 5: Primer Forward: 5’ AACACGAGCGATGGACCAAA 3’, Primer Reverse: 3’
AAAGACATGGCAGCAAGGA 5’
• Primers mGluR 1/mGluR 5 (Primer 3 software design)
• Real-Time PCR
11. Specific Aim #2
• To determine localization of mGluR 1 and mGluR 5 in whole-brain
adult Zebrafish.
• Dissection of Zebrafish adult brain
• anesthetize fish in 120uL/50ml dilution of isoflurane
• Tissue Dehydration
• 4% formaldehyde whole Zebrafish brain
• Series alcohol concentration
• Group I mGluRs Immunohistochemistry
• slice (4-7 um in thickness)
• mAB rabbit mGluR1 (1:50)
12. IHC Process
Formalin-Fixed
Paraffin Embedded tissue
Prepare sections and mount on
slides
Add Primary antibody
Add HRP-linked Ab
Detect with DAB chromagen
Counterstain with hematoxylin
and Interpret result
13. Group I mGluR Expression
Muñoz et al. J Comparative Neurology, 1999.
14. Future Directions
• Our laboratory should direct its future experiments toward:
• Drug response assay
• Immunohistochemical analysis (Habenula)
• electrophysiological activity and molecular presence of
mGluRs
• To study the effect of mGluR on shoaling behavior
15. Acknowledgements
• Dr. Zaira Mateo
• Dr. Gladys Chompre
• Dr. Dinah Ramos
• Dr. Olga Santiago
• Dr. James Porter (PSM)
• Daisy Morales
• Undergraduate Student
• Roberto León
• Pedro Colon
• Maite León
• CEIBA BTEC program
16.
17. References
• Kalueff, A., Stewart, A., & Gerlai, R. (2014, January 31). Zebrafish as an emerging
model for studying complex brain disorders. Trends in pharmacological sciences.
doi:10.1016/j.tips.2013.12.002
• Sidoryk-Wegrzynowicz, M., & Aschner, M. (2013, April 30). Manganese toxicity in
the central nervous system: the glutamine/glutamate-γ-aminobutyric acid
cycle. Journal of internal medicine. doi:10.1111/joim.12040
• Teles, M., Dahlbom, S., Winberg, S., & Oliveira, R. (2013, September 14). Social
modulation of brain monoamine levels in zebrafish. Behavioural brain research.
doi:10.1016/j.bbr.2013.07.012
• Haug, M., Gesemann, M., Mueller, T., & Neuhauss, S. (2013, April 30). Phylogeny
and expression divergence of metabotropic glutamate receptor genes in the brain
of zebrafish (Danio rerio). The Journal of comparative neurology.
doi:10.1002/cne.23240
18. References
• Magi, S., Arcangeli, S., Castaldo, P., Nasti, A., Berrino, L., Piegari, E., Bernardini, R.,
et al. (2013, September 30). Glutamate-Induced ATP Synthesis: Relationship
between Plasma Membrane Na+/Ca2+ Exchanger and Excitatory Amino Acid
Transporters in Brain and Heart Cell Models. Molecular pharmacology.
doi:10.1124/mol.113.087775
• McKenna, M. (2012, October 31). Substrate competition studies demonstrate
oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-
hydroxybutyrate in cortical astrocytes from rat brain. Neurochemical research.
doi:10.1007/s11064-012-0901-3
• Gerlai, R., Chatterjee, D., Pereira, T., Sawashima, T., & Krishnannair, R. (2009, July
31). Acute and chronic alcohol dose: population differences in behavior and
neurochemistry of zebrafish. Genes, brain, and behavior. doi:10.1111/j.1601-
183X.2009.00488.x
• Scerbina, T., Chatterjee, D., & Gerlai, R. (2012, October 31). Dopamine receptor
antagonism disrupts social preference in zebrafish: a strain comparison study.
Amino acids. doi:10.1007/s00726-012-1284-0
Editor's Notes
AMPA-Mediates fast synaptic transmission in CNS
NMDA/glycine- Improves synaptic transmission. Role in synaptic plasticity and memory. Located in post synaptic membrane.
Kainate- Involved excitatory neurotransmission. Located in Pre-synaptic membrane, involved in modulating the release of GABA
Metabotropic glu receptor are g-protein coupled receptors that have been subdivided into three groups.
mGlur III- Decrease NMDA receptor activity- mGluRs 4, 6, 7, and 8
mGlurR I- increases NMDA activity- mGluR1 , mGluR5
mGluR II- decreases NMDA activity- mGluR2 , mGluR3
Glutamate is the major excitatory neurotransmitter in the mammalians Central Nerve System.
It act via two classes of receptors, ligand gated ion channels, and G-protein coupled.
To test our hypothesize
To complete
will be homogenized and centrifuged
are expressed where thalamocortical axons terminate